Human iPSCs: atrial versus ventricular cardiomyocytes and their functional and pharmacological differences

Download

Authors: Steven David Broadbent, Jamie Ronald Bhagwan, Tosin Olusoga, and Ashley Barnes

Biochemical Society Transactions, 27 January 2026

Related Resources
Activation of IP3R in atrial cardiomyocytes leads to generation of cytosolic cAMP
Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell–Derived Ventricular Cardiomyocytes Using Multielectrode Array
Comparative analysis of the cardiomyocyte differentiation potential of induced pluripotent stem cells reprogrammed from human atrial or ventricular fibroblasts

Related Products

System

Axion MEA

MEA and HD-MEA systems for advanced electrophysiology

Learn more >>
Axion MEA family - Synexus, Maestro Pro, Maestro Edge and Maestro Volt
Software

Cardiac Module

Record the four key measures of cardiac performance: action potential, field potential, propagation, and contractility

Learn more >>
Axion BioSystems Cardiac software Module for MEA experiments
Consumable

CytoView MEA Plate

The premium Maestro MEA plate with a transparent well bottom for cell visualization and assay multiplexing

Learn more >>
Axion BioSystems CytoView MEA plate